Dr Ian Godsland is Wynn Reader in Human Metabolism at Imperial College London. He is undertaking long-term investigations into metabolic risk factors for diabetes and cardiovascular disease in the context of a range of studies, in particular a cohort study in which intensive metabolic investigations were carried out for 29 years. His main focus is on the measurement and definition of insulin resistance, insulin secretion and the metabolic syndrome, and their roles in type 2 diabetes and coronary heart disease. He also has an extensive background in metabolic risk factor changes associated with use of gonadal steroids,especially oral contraceptive and postmenopausal hormone replacement therapies.
et al., 2022, A game for all shapes and sizes? Changes in anthropometric and performance measures of elite professional rugby union players 1999-2018, Bmj Open Sport and Exercise Medicine, Vol:8, ISSN:2055-7647, Pages:1-9
et al., 2021, Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures, Diabetes Obesity & Metabolism, Vol:23, ISSN:1462-8902, Pages:2521-2528
et al., 2021, Mortality risk in patients with adrenal insufficiency using prednisolone or hydrocortisone: a retrospective cohort study, Journal of Clinical Endocrinology and Metabolism, Vol:106, ISSN:0021-972X, Pages:2242-2251
et al., 2021, Cross-sectional analysis of emergency hypoglycaemia and outcome predictors among people with diabetes in an urban population, Diabetic Medicine, Vol:38, ISSN:0742-3071